SARS-CoV-2 testing among patients and healthcare professionals in an HIV outpatient clinic in Brazil

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorSecretaria Municipal de Saúde-
Autor(es): dc.contributorUniversidade do Estado de São Paulo-
Autor(es): dc.contributorCentro de Laboratório Regional Santo André-
Autor(es): dc.contributorCentro de Virologia-
Autor(es): dc.contributorCentro de Imunologia-
Autor(es): dc.creatorMatsuda, Elaine Monteiro-
Autor(es): dc.creatorde Oliveira, Isabela Penteriche-
Autor(es): dc.creatorde Campos, Ivana Barros-
Autor(es): dc.creatorAhagon, Cintia Mayumi-
Autor(es): dc.creatorCastejon, Marcia Jorge-
Autor(es): dc.creatorSilva, Valeria Oliveira-
Autor(es): dc.creatorManzoni, Fernanda Matsuda-
Autor(es): dc.creatorLópez-Lopes, Giselle Ibette-
Autor(es): dc.creatorBrígido, Luís Fernando de Macedo-
Data de aceite: dc.date.accessioned2025-08-21T21:34:15Z-
Data de disponibilização: dc.date.available2025-08-21T21:34:15Z-
Data de envio: dc.date.issued2022-04-29-
Data de envio: dc.date.issued2022-04-29-
Data de envio: dc.date.issued2021-12-31-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1590/S1678-9946202264003-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/231615-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/231615-
Descrição: dc.descriptionThe COVID-19 pandemic in Brazil has been marked by high infection and death rates. The immune response generated by current vaccination might be influenced by previous natural infection, and baseline estimates may help in the evaluation of vaccine-induced serological response. We evaluated previous SARS-CoV-2 testing (RT-PCR), and performed rapid diagnostic tests (RDT) and high throughput electrochemiluminescence immunoassay (ECLIA) before vaccination among people living with HIV (PLWH), users of antiretroviral prophylaxis (PrEP/PEP), and healthcare professionals in an HIV outpatient clinic (HCP-HC). RDT was positive in 25.7% (95% CI: 19-33%) overall, 31.3% (95% CI: 18-45%) among PLWH, 23.7% (95% CI: 14-34%) in PrEP/PEP users and 21.4% (95% CI: 05-28%) in HCP-HC (p=0.548). Diagnostic RT-PCR testing was very limited, even for symptomatic individuals, and whereas all HCP-HC had one test perfomed, only 35% of the patients (PREP/ PEP/PLWH) were tested (p<0.0001). Adequate monitoring of post-vaccination humoral response and breakthrough infections including those in asymptomatic cases are warranted, especially in immunologically compromised individuals.-
Descrição: dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)-
Descrição: dc.descriptionSecretaria Municipal de Saúde, São Paulo-
Descrição: dc.descriptionUniversidade do Estado de São Paulo, Campus Botucatu, São Paulo-
Descrição: dc.descriptionInstituto Adolfo Lutz Centro de Laboratório Regional Santo André, São Paulo-
Descrição: dc.descriptionInstituto Adolfo Lutz Centro de Virologia, São Paulo-
Descrição: dc.descriptionInstituto Adolfo Lutz Centro de Imunologia, São Paulo-
Descrição: dc.descriptionCNPq: 24/2019-442776/2019-5-
Idioma: dc.languageen-
Relação: dc.relationRevista do Instituto de Medicina Tropical de Sao Paulo-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectHealth care personals-
Palavras-chave: dc.subjectHIV-
Palavras-chave: dc.subjectPEP-
Palavras-chave: dc.subjectPrEP-
Palavras-chave: dc.subjectPrevalence-
Palavras-chave: dc.subjectSARS-CoV-2-
Título: dc.titleSARS-CoV-2 testing among patients and healthcare professionals in an HIV outpatient clinic in Brazil-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.